Xiong ZZ - Search Results

1

UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer.

Xiao J, Sun F, Wang YN, Liu B, Zhou P, Wang FX, Zhou HF, Ge Y, Yue TT, Luo JH, Yang CL, Rong SJ, Xiong ZZ, Ma S, Zhang Q, Xun Y, Yang CG, Luan Y, Wang SG, Wang CY, Wang ZH. Xiao J, et al. Among authors: xiong zz. J Clin Invest. 2023 Feb 15;133(4):e158352. doi: 10.1172/JCI158352. J Clin Invest. 2023. PMID: 36626227 Free PMC article.

2

GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.

Xiong Z, Ge Y, Xiao J, Wang Y, Li L, Ma S, Lan L, Liu B, Qin B, Luan Y, Yang C, Ye Z, Wang Z. Xiong Z, et al. Exp Biol Med (Maywood). 2023 Jan;248(1):1-13. doi: 10.1177/15353702221131888. Epub 2022 Nov 20. Exp Biol Med (Maywood). 2023. PMID: 36408742 Free PMC article.

3

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.

Ma S, Ge Y, Xiong Z, Wang Y, Li L, Chao Z, Li B, Zhang J, Ma S, Xiao J, Liu B, Wang Z. Ma S, et al. PeerJ. 2023 Feb 8;11:e14784. doi: 10.7717/peerj.14784. eCollection 2023. PeerJ. 2023. PMID: 36785707 Free PMC article.

4

Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics.

Li L, Chao Z, Waikeong U, Xiao J, Ge Y, Wang Y, Xiong Z, Ma S, Wang Z, Hu Z, Zeng X. Li L, et al. J Transl Med. 2023 Feb 24;21(1):146. doi: 10.1186/s12967-023-03978-y. J Transl Med. 2023. PMID: 36829161 Free PMC article.

5

Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.

Li L, Zeng X, Chao Z, Luo J, Guan W, Zhang Q, Ge Y, Wang Y, Xiong Z, Ma S, Zhou Q, Zhang J, Tian J, Horne D, Yuh B, Hu Z, Wei GH, Wang B, Zhang X, Lan P, Wang Z. Li L, et al. Adv Sci (Weinh). 2023 Sep;10(27):e2301975. doi: 10.1002/advs.202301975. Epub 2023 Aug 1. Adv Sci (Weinh). 2023. PMID: 37526345 Free PMC article.

6

Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinoma.

Ge Y, Ma S, Zhang J, Xiong Z, Li B, Ma S, Liu B, Yao X, Wang Z. Ge Y, et al. Cancer Med. 2023 Sep;12(18):19320-19336. doi: 10.1002/cam4.6504. Epub 2023 Sep 7. Cancer Med. 2023. PMID: 37676078 Free PMC article.

7

Oncogene goosecoid is transcriptionally regulated by E2F1 and correlates with disease progression in prostate cancer.

Ge Y, Ma S, Zhou Q, Xiong Z, Wang Y, Li L, Chao Z, Zhang J, Li T, Wu Z, Gao Y, Qu G, Xi Z, Liu B, Wu X, Wang Z. Ge Y, et al. Chin Med J (Engl). 2023 Nov 24. doi: 10.1097/CM9.0000000000002865. Online ahead of print. Chin Med J (Engl). 2023. PMID: 37997674

8

Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study.

Sulaiman M, Ali KA, Chunguang Y, Hashim R, Luan Y, Xiong ZZ, Huang H, Wang Z. Sulaiman M, et al. Among authors: xiong zz. Surg Endosc. 2024 Apr 24. doi: 10.1007/s00464-024-10848-1. Online ahead of print. Surg Endosc. 2024. PMID: 38658391

9

Risk factors for postoperative recurrence in patients with stage II colorectal cancer.

Xiong ZZ, Xie MH, Li XZ, Jin LY, Zhang FX, Yin S, Chen HX, Lian L. Xiong ZZ, et al. BMC Cancer. 2023 Jul 14;23(1):658. doi: 10.1186/s12885-023-11093-w. BMC Cancer. 2023. PMID: 37452325 Free PMC article.

10

Diverse interactions of five core type III effectors from Ralstonia solanacearum with plants.

Cong S, Li JZ, Xiong ZZ, Wei HL. Cong S, et al. Among authors: xiong zz. J Genet Genomics. 2023 May;50(5):341-352. doi: 10.1016/j.jgg.2022.04.018. Epub 2022 May 18. J Genet Genomics. 2023. PMID: 35597445 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page